[December 15, 2017] |
|
Complera 2016-2017 U.S. Promotional Activity Report - Research and Markets
The "Complera
2016 U.S Promotional Report" report has been added to Research
and Markets' offering.
The 5 Key Questions Addressed by this Report:
-
How many physicians were reached by Complera through personal
promotion in 2016 and how does this compare to its peer set in the HIV
markets?
-
What promotional mix was leveraged (e.g., sales rep detailing,
physician education, and paid speaking) and what was the median spend
on each type of activity?
-
How does J&J's depth of coverage vary within key specialties (e.g.,
Infectious Disease, Internal Medicine, and Family Medicine) and how
does this compare to its peers and the overall set of rep-accessible
physician?
-
How often are physicians receiving paid meals for Complera throughout
the year (e.g., monthly, quarterly, annually)?
-
Who were the most detailed prescribers and top paid speakers for
Complera in 2016?
Data Sources and Methodology:
-
We leverage company-reported financial transaction data disclosed
through CMS Open Payments. This data set captures all transfers of
value (e.g., speaking fees, consulting fees, travel, education, and
meals) made on behalf of a drug or device manufacturer to a physician.
Currently, 42 months of longitudinal data is available - covering
payments to more than 900,000 U.S. healthcare professionals.
-
Over 1,200 paid interactions across 500 physicians made on behalf of
Complera were carefully examined to support our analysis. In addition,
interaction data from 11 peer products (e.g. Descovy, Evotaz, Genvoya,
Isentress, Odefsey, Prezcobix, Prezista, Sustiva, Tivicay, Triumeq,
and Viread) was leveraged to provide benchmarking and market insights.
For more information about this report visit https://www.researchandmarkets.com/research/fg6f4j/complera?w=4
View source version on businesswire.com: http://www.businesswire.com/news/home/20171215005715/en/
[ Back To TMCnet.com's Homepage ]
|